SCHEMBL8965509

SCHEMBL8965509

COc1cc(C=CC2=NNC(=O)CC2)cc(OC)c1OC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 5/20 0.63
▸ SMN1; SMN2 Q16637 4/20 0.63
▸ RAB9A P51151 3/20 0.63
▸ KDM4E B2RXH2 2/20 0.63
▸ L3MBTL1 Q9Y468 1/20 0.63
▸ PTGS1 P23219 3/20 0.60
▸ PTGS2 P35354 3/20 0.60
▸ MAPT P10636 2/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ POLB P06746 1/20 0.52
▸ GAA P10253 1/20 0.52
▸ PKM P14618 1/20 0.52
▸ HSD17B3 P37058 1/20 0.47
▸ TUBB1 Q9H4B7 8/20 0.47
▸ TUBB4A P04350 6/20 0.47
▸ TUBB P07437 6/20 0.47
▸ TUBA3C P0DPH7 6/20 0.47
▸ TUBA1B P68363 6/20 0.47
▸ TUBA4A P68366 6/20 0.47
▸ TUBB4B P68371 6/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10766056 0.89 LMNA (0.54) LMNASMN1; SMN2RAB9AKDM4EL3MBTL1
SCHEMBL10761225 0.89 LMNA (0.54) LMNASMN1; SMN2RAB9AKDM4EL3MBTL1
SCHEMBL10764764 0.87 LMNA (0.52) LMNASMN1; SMN2RAB9AKDM4EL3MBTL1
SCHEMBL10765198 0.85 LMNA (0.59) LMNASMN1; SMN2RAB9AKDM4EL3MBTL1
SCHEMBL10765902 0.85 SMN1; SMN2 (0.69) LMNASMN1; SMN2RAB9AKDM4EL3MBTL1
SCHEMBL10760153 0.83 LMNA (0.56) LMNASMN1; SMN2RAB9AKDM4EL3MBTL1
SCHEMBL10764736 0.82 LMNA (0.64) LMNASMN1; SMN2RAB9AKDM4EL3MBTL1
SCHEMBL10760888 0.81 LMNA (0.60) LMNASMN1; SMN2RAB9AKDM4EL3MBTL1
SCHEMBL10761723 0.80 RAB9A (0.62) LMNASMN1; SMN2RAB9AKDM4EL3MBTL1
SCHEMBL10762692 0.79 LMNA (0.64) LMNASMN1; SMN2RAB9AKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5538970-A Treatment of cancer with imidazo-1,2-pyridazin compounds GLAXO WELLCOME INC. (US) 1996-07-23 — — US disclosed
US-5447956-A Anticarcinogenic agents BURROUGHS WELLCOME CO. (US) 1995-09-05 — — US disclosed
US-5380759-A Methyl N-[6-(3,4,5-trimethoxybenzloxy)imidazo[1,2-b]pyridazin-2-zyl]carbamate used to treat leukemia BURROUGHS WELLCOME CO. (US) 1995-01-10 — — US disclosed
US-5371219-A Antitumor agents BURROUGHS WELLCOME CO. (US) 1994-12-06 — — US disclosed
EP-0305093-B1 Imidazo(1,2-b)pyridazine derivatives WELLCOME FOUND (GB) 1994-04-06 — — EP disclosed
US-5091531-A Antitumor agents BURROUGHS WELLCOME CO. (US) 1992-02-25 — — US disclosed
EP-0305093-A1 Imidazo(1,2-b)pyridazine derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1989-03-01 — — EP disclosed
Send feedback